卡利斯托·科蘇里奇

Recent publications · Crossref

5 total works indexed

1. AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with <i>In vitro</i> and <i>In vivo</i> Antitumor Activity

   · 2010 · cited 718x

2. Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background

   · 2012 · cited 426x

3. Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor

   · 2016 · cited 422x

4. Defining total-body AIDS-virus burden with implications for curative strategies

   · 2017 · cited 404x

5. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)

   · 2009 · cited 395x

via Crossref · CC0

Wikidata facts

via Wikidata · CC0